# Diabetes Research Hub — Daily Iteration Report
**Date:** 2026-06-05 (Friday) — Automated scheduled iteration

## Work completed

### Path validation (4 paths -> VALIDATED)
1. **NLRP3_inflammasome -> inflammation** — VALIDATED. NF-kB priming -> caspase-1 -> IL-1b/IL-18 maturation drives glomerular/tubular injury in DKD; NLRP3 activation precedes albuminuria. Ext: PMC12395217, PMC9218738; corpus PMID 41357229.
2. **dapagliflozin -> nephropathy** — VALIDATED. DAPA-CKD RCT (n=4304; baseline PMID 32862232; NEJMoa2024816): reduced eGFR decline >=50%/ESKD/renal-or-CV death and albuminuria, with/without T2D.
3. **verapamil -> beta_cell** — VALIDATED. 2018 RCT + 2023 meta-analysis (PMC10424102): improved stimulated C-peptide AUC at 3 & 12 mo vs placebo in recent-onset T1D via TXNIP suppression.
4. **oxidative_stress -> inflammation** — VALIDATED. ROS -> NF-kB priming of NLRP3 -> pro-IL-1b/IL-18 transcription (Front Physiol 2018, PMC5826188).

Concrete-rating validated paths now 14; ~37 unvalidated remain.

### Credibility sweep — CLEAN
No fabricated PMIDs (>42000000). Only "curative"/"zero rejection" matches are inside detector script verify_before_deploy.py; "achieves" matches are benign design/modeling descriptors.

### Pipeline rebuild — 41/41 [OK]

## Carried forward
- Weekly PubMed new-paper scan skipped (Friday, not Monday).
- Vetting coverage: 272 VETTED / 13 FLAGGED of 285; no UNVETTED.
- PRIORITY-1 BLOCKER: ~33 commits unpushed. Sandbox push fails (no GitHub auth) + OneDrive-locked .git/*.lock. User: from PowerShell run `Remove-Item .git\HEAD.lock; Remove-Item .git\index.lock; git add -A; git commit -m 'Daily iterations'; git push origin main`.

## Next run
- Validate: hydroxychloroquine->T2D, metformin->T2D, NF_kB->inflammation, dorzagliatin->T2D.
- Gap audits late June: #14 (06-25), #11 (06-27), #1 (06-29).
- Monday: weekly PubMed scan.
